Skip to content

H.R. 384 · 118th Congress (2023–2025)

Protecting Life from Chemical Abortions Act

This bill nullifies certain changes made by the Food and Drug Administration (FDA) to dispensing requirements for mifepristone. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.)

The FDA regulates the use of mifepristone through the Mifepristone Risk Evaluation and Mitigation Strategy (REMS) program. The program requires health care providers to comply with certain requirements in order to prescribe or dispense mifepristone to end a pregnancy; the program previously included an in-person dispensing requirement that required mifepristone to be directly dispensed to patients in clinics, medical offices, or hospitals. During the COVID-19 public health emergency, the FDA temporarily stopped enforcing the in-person dispensing requirement, which allowed mail-order pharmacies to fill and dispense mifepristone prescriptions.

In January 2023, the FDA modified program requirements so as to (1) remove the in-person dispensing requirement, and (2) require pharmacies to be certified in the program in order to dispense mifepristone. The modifications allow retail pharmacies, after receiving certification, to dispense mifepristone pursuant to prescriptions that are written by program-certified prescribers.

The bill nullifies the January 2023 changes and prohibits the FDA from (1) exercising any enforcement discretion with respect to program requirements, or (2) reducing program protections until every state submits certain data regarding abortions to the Centers for Disease Control and Prevention.

The bill also generally prohibits the declaration of a public health emergency with respect to abortions.


Show official title

To prohibit the use or declaration of a public health emergency with respect to abortion, and for other purposes.

Expired in House committee

Derived from the legislative history, not an official disposition.

Latest actionReferred to Health

This bill’s path

This is H.R. 384’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Rep. Kevin Hern (R-OK-1)
Cosponsors
40 cosponsors

34 original · 6 later

40 R

  1. Rep. Robert B. Aderholt (R-AL-4)· Original · Jan 17, 2023
  2. Rep. Lauren Boebert (R-CO-3)· Original · Jan 17, 2023
  3. Rep. Brian Babin (R-TX-36)· Original · Jan 17, 2023
  4. Rep. Jim Banks (R-IN-3)· Original · Jan 17, 2023
  5. Rep. James R. Baird (R-IN-4)· Original · Jan 17, 2023
  6. Rep. Andrew S. Clyde (R-GA-9)· Original · Jan 17, 2023
  7. Rep. Ben Cline (R-VA-6)· Original · Jan 17, 2023
  8. Rep. Jeff Duncan (R-SC-3)· Original · Jan 17, 2023
  9. Rep. Jake Ellzey (R-TX-6)· Original · Jan 17, 2023
  10. Rep. Randy Feenstra (R-IA-4)· Original · Jan 17, 2023
  11. Rep. Brad Finstad (R-MN-1)· Original · Jan 17, 2023
  12. Rep. Russell Fry (R-SC-7)· Original · Jan 17, 2023
  13. Rep. Paul A. Gosar (R-AZ-9)· Original · Jan 17, 2023
  14. Rep. Glenn Grothman (R-WI-6)· Original · Jan 17, 2023
  15. Rep. Mark E. Green (R-TN-7)· Original · Jan 17, 2023
  16. Rep. Michael Guest (R-MS-3)· Original · Jan 17, 2023
  17. Rep. Diana Harshbarger (R-TN-1)· Original · Jan 17, 2023
  18. Rep. Ashley Hinson (R-IA-2)· Original · Jan 17, 2023
  19. Rep. Ronny Jackson (R-TX-13)· Original · Jan 17, 2023
  20. Rep. Trent Kelly (R-MS-1)· Original · Jan 17, 2023
  21. Rep. Doug Lamborn (R-CO-5)· Original · Jan 17, 2023
  22. Rep. Doug LaMalfa (R-CA-1)· Original · Jan 17, 2023
  23. Rep. Barry Loudermilk (R-GA-11)· Original · Jan 17, 2023
  24. Rep. Nicholas A. Langworthy (R-NY-23)· Original · Jan 17, 2023
  25. Rep. John R. Moolenaar (R-MI-2)· Original · Jan 17, 2023
  26. Rep. Brian J. Mast (R-FL-21)· Original · Jan 17, 2023
  27. Rep. Mary E. Miller (R-IL-15)· Original · Jan 17, 2023
  28. Rep. August Pfluger (R-TX-11)· Original · Jan 17, 2023
  29. Rep. John H. Rutherford (R-FL-5)· Original · Jan 17, 2023
  30. Rep. John W. Rose (R-TN-6)· Original · Jan 17, 2023
  31. Rep. Pete Sessions (R-TX-17)· Original · Jan 17, 2023
  32. Rep. Daniel Webster (R-FL-11)· Original · Jan 17, 2023
  33. Rep. Randy K. Weber, Sr. (R-TX-14)· Original · Jan 17, 2023
  34. Rep. Brad R. Wenstrup (R-OH-2)· Original · Jan 17, 2023
  35. Rep. Mike Bost (R-IL-12)· Later · Mar 21, 2023
  36. Rep. Bob Good (R-VA-5)· Later · Mar 21, 2023
  37. Rep. Keith Self (R-TX-3)· Later · Mar 21, 2023
  38. Rep. Rudy Yakym III (R-IN-2)· Later · Mar 21, 2023
  39. Rep. Dan Crenshaw (R-TX-2)· Later · Sep 18, 2023
  40. Rep. Dan Newhouse (R-WA-4)· Later · Mar 29, 2024
Policy area
Health

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest
    ▸ 2 committee actions · Jan 17, 2023 – Jan 27, 2023
    1. Referred to committee

      Referred to the House Committee on Energy and Commerce.

      Sources
    2. Referred to Health

      Referred to the Subcommittee on Health.

      Sources
  3. Expired

    Introduced → Referred to House Health → No further action before the 118th Congress ended.

Committees

  1. HouseEnergy and CommerceReferred Jan 17, 2023
  2. HouseHealthReferred Jan 27, 2023

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (2)
  1. Protecting Life from Chemical Abortions Act

    Display title, Short title · Introduced in House

  2. To prohibit the use or declaration of a public health emergency with respect to abortion, and for other purposes.

    Official title · Introduced in House